Found 513 results
Chris Deacon’s tireless efforts led to a $100 million settlement with Horizon Blue Cross Blue Shield, though her contrib...
The current Ebola outbreak in the DRC faces severe obstacles to containment, risking a permanent endemic situation that...
With rising expenses, small companies are increasingly unable to provide health insurance, impacting millions of America...
Vertex Pharmaceuticals is set to acquire Crinetics Pharmaceuticals for $10 billion, marking a pivotal expansion into rar...
A recent analysis of GLP-1 telehealth platforms reveals significant variation in service quality, highlighting the need...
The decline of employer-based health insurance is straining workers and businesses, raising serious concerns about its s...
Recent studies suggest that psilocybin therapy may offer enduring relief for patients with depression, presenting a sign...
After a distressing buyout, Bluebird Bio's transformation into Genetix positions it to lead the market in sickle cell ge...
Experts suggest reintroducing the presidential fitness test is a positive move but insufficient alone to address childho...
UpDoc's FDA-cleared app integrates large language models to assist diabetes management, sparking conversations about AI'...
The biotech sector has experienced a remarkable rise in performance, with major indices celebrating significant gains as...
Frequent and severe heat waves are significantly impacting public health, with rising temperatures posing increased risk...
A recent court ruling benefits Amgen, blocking a price cap on Enbrel, while Medicare expands access to obesity medicatio...
Roche's new KRAS-targeted therapy is poised to redefine lung cancer treatment, showing impressive efficacy and safety in...
Elevance Health has initiated legal action against the U.S. government, claiming improper recalculation of its Medicare...
Medicare plans to reduce payments for 340B drugs by over 33%, a move criticized for potentially harming safety-net hospi...
A recent revelation exposes the alcohol industry's significant financial influence on public health organizations, impac...
The third quarter of 2026 promises significant biotech events, including critical trial results that could impact stock...
Current diagnostic strategies for Ebola and Marburg viruses fail to adapt to the complexities of overlapping outbreaks,...
Orca Bio receives FDA approval for Tregzi, a personalized T-cell therapy aimed at reducing complications in blood cancer...